Cited by 157Cannabis and Cannabinoid ResearchEnzyme function and inhibitionEicosanoids and Hypertension Pharmacology

Evaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors

Open access
Niphakis, Micah J., Cognetta, Armand B., Chang, Jae Won, Buczynski, Matthew W., Parsons, Loren H., Byrne, Frederika, Burston, James J., Chapman, Victoria +1 more·2013·ACS Chemical Neuroscience

Abstract

Monoacylglycerol lipase (MAGL) is a principal metabolic enzyme responsible for hydrolyzing the endogenous cannabinoid (endocannabinoid) 2-arachidonoylglycerol (2-AG). Selective inhibitors of MAGL offer valuable probes to further understand the enzyme's function in biological systems and may lead to drugs for treating a variety of diseases, including psychiatric disorders, neuroinflammation, and pain. N-Hydroxysuccinimidyl (NHS) carbamates have recently been identified as a promising class of serine hydrolase inhibitors that shows minimal cross-reactivity with other proteins in the proteome. Here, we explore NHS carbamates more broadly and demonstrate their potential as inhibitors of endocannabinoid hydrolases and additional enzymes from the serine hydrolase class. We extensively characterize an NHS carbamate 1a (MJN110) as a potent, selective, and in-vivo-active MAGL inhibitor. Finally, we demonstrate that MJN110 alleviates mechanical allodynia in a rat model of diabetic neuropathy, marking NHS carbamates as a promising class of MAGL inhibitors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/cn400116z

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Niphakis, M. J., Cognetta, A. B., Chang, J. W., Buczynski, M. W., Parsons, L. H., Byrne, F., Burston, J. J., Chapman, V., & Cravatt, B. F.
Affiliations
  • Scripps Research Institute (US)
  • University of Nottingham (GB)
Corresponding author
  • Niphakis, Micah J.
  • Cravatt, Benjamin F.
Venue
ACS Chemical Neuroscience
Published
2013-06-17
Volume
4
Issue
9
Pages
1322-1332
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2040580317
Cited by
157
References
57
Citations by year
2026: 15 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 11 · 2021: 23 · 2020: 10 · 2019: 11 · 2018: 15 · 2017: 9 · 2016: 11 · 2015: 12 · 2014: 8 · 2013: 1
FWCI
8.08
Type
journal article
Language
en
Open access
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
Funders
  • National Institutes of Health (DA017259)
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council
  • National Institute on Alcohol Abuse and Alcoholism (R01AA020404)
  • National Institute on Drug Abuse (DA033760, F32DA032541, DA-017259, DA032933, R01DA032933, R01DA033760, P01DA017259, F32DA029994, DA032541)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
monoacylglycerol lipase, MAGL inhibitors, 2-arachidonoylglycerol, serine hydrolase inhibitors, mechanical allodynia, diabetic neuropathy, in vivo enzyme inhibition
MeSH terms
Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Blood Glucose, Brain, Carbamates, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Drug Evaluation, Preclinical, Humans, Hyperalgesia, Insulin, Liver, Male, Monoacylglycerol Lipases, Species Specificity, Structure-Activity Relationship, Succinimides, Molecular Structure, Rats, Sprague-Dawley, Mice, Rats, HEK293 Cells, Nociception, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review